Novo Integrated Sciences NVOS Stock
Novo Integrated Sciences Price Chart
Novo Integrated Sciences NVOS Financial and Trading Overview
Novo Integrated Sciences stock price | 0.0010 USD |
Previous Close | 0.13 USD |
Open | 0.13 USD |
Bid | 0 USD x 1300 |
Ask | 0 USD x 1200 |
Day's Range | 0.13 - 0.13 USD |
52 Week Range | 0.1 - 2.14 USD |
Volume | 3.07M USD |
Avg. Volume | 11.74M USD |
Market Cap | 19.48M USD |
Beta (5Y Monthly) | -0.175 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.33 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NVOS Valuation Measures
Enterprise Value | 22.71M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.6677315 |
Price/Book (mrq) | 0.6897436 |
Enterprise Value/Revenue | 1.944 |
Enterprise Value/EBITDA | -3.052 |
Trading Information
Novo Integrated Sciences Stock Price History
Beta (5Y Monthly) | -0.175 |
52-Week Change | -92.89% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.14 USD |
52 Week Low | 0.1 USD |
50-Day Moving Average | 0.14 USD |
200-Day Moving Average | 0.33 USD |
NVOS Share Statistics
Avg. Volume (3 month) | 11.74M USD |
Avg. Daily Volume (10-Days) | 7.05M USD |
Shares Outstanding | 144.86M |
Float | 122.58M |
Short Ratio | 0.31 |
% Held by Insiders | 12.92% |
% Held by Institutions | 3.29% |
Shares Short | 3.69M |
Short % of Float | 2.79% |
Short % of Shares Outstanding | 2.54% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | August 31, 2022 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | August 31, 2023 |
Profitability
Profit Margin | -297.82% |
Operating Margin (ttm) | -86.71% |
Gross Margin | 43.02% |
EBITDA Margin | -63.68% |
Management Effectiveness
Return on Assets (ttm) | -11.85% |
Return on Equity (ttm) | -97.77% |
Income Statement
Revenue (ttm) | 11.68M USD |
Revenue Per Share (ttm) | 0.27 USD |
Quarterly Revenue Growth (yoy) | -10.90% |
Gross Profit (ttm) | N/A |
EBITDA | -7440325 USD |
Net Income Avi to Common (ttm) | -34794228 USD |
Diluted EPS (ttm) | -1.03 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 609.74K USD |
Total Cash Per Share (mrq) | 0.004 USD |
Total Debt (mrq) | 4.34M USD |
Total Debt/Equity (mrq) | 16.09 USD |
Current Ratio (mrq) | 0.656 |
Book Value Per Share (mrq) | 0.195 |
Cash Flow Statement
Operating Cash Flow (ttm) | -4031234 USD |
Levered Free Cash Flow (ttm) | 293.63K USD |
Profile of Novo Integrated Sciences
Country | United States |
State | WA |
City | Bellevue |
Address | 11120 NE 2nd Street |
ZIP | 98004 |
Phone | (206) 617-9797 |
Website | https://www.novointegrated.com |
Industry | Medical Care Facilities |
Sector(s) | Healthcare |
Full Time Employees | 115 |
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates corporate-owned clinics. The company is based in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.
Q&A For Novo Integrated Sciences Stock
What is a current NVOS stock price?
Novo Integrated Sciences NVOS stock price today per share is 0.0010 USD.
How to purchase Novo Integrated Sciences stock?
You can buy NVOS shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novo Integrated Sciences?
The stock symbol or ticker of Novo Integrated Sciences is NVOS.
Which industry does the Novo Integrated Sciences company belong to?
The Novo Integrated Sciences industry is Medical Care Facilities.
How many shares does Novo Integrated Sciences have in circulation?
The max supply of Novo Integrated Sciences shares is 19.73M.
What is Novo Integrated Sciences Price to Earnings Ratio (PE Ratio)?
Novo Integrated Sciences PE Ratio is now.
What was Novo Integrated Sciences earnings per share over the trailing 12 months (TTM)?
Novo Integrated Sciences EPS is -1.33 USD over the trailing 12 months.
Which sector does the Novo Integrated Sciences company belong to?
The Novo Integrated Sciences sector is Healthcare.
Novo Integrated Sciences NVOS included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 17689.66 USD — |
-0.87
|
6.38B USD — | 17592.88 USD — | 17830.35 USD — | — - | 6.38B USD — |
NASDAQ HealthCare IXHC | 906.89 USD — |
-4.12
|
— — | 905.36 USD — | 931.92 USD — | — - | — — |
- {{ link.label }} {{link}}